scispace - formally typeset
S

Soumya Swaminathan

Researcher at Indian Council of Medical Research

Publications -  370
Citations -  78067

Soumya Swaminathan is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Tuberculosis & Population. The author has an hindex of 69, co-authored 353 publications receiving 61963 citations. Previous affiliations of Soumya Swaminathan include Yahoo! & Ministry of Health and Family Welfare.

Papers
More filters
Journal ArticleDOI

HIV prevention interventions in Chennai, India: are men who have sex with men being reached?

TL;DR: Understanding predictors of participation in an HIV prevention intervention is helpful for identifying Indian MSM who might have had no exposure to HIV prevention information and skills building, hence allowing researchers and prevention workers to focus efforts on individuals at greatest need.
Journal ArticleDOI

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.

TL;DR: The linezolid AUC0–24/MIC target for optimal efficacy against pediatric intracellular tuberculosis, and an AUC1–24 threshold associated with mitochondrial inhibition are identified, constituting a therapeutic window to be targeted for optimal lineZolid doses in children with tuberculosis.
Journal ArticleDOI

Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India.

TL;DR: Low RMP concentrations were associated with treatment outcome and alcohol use significantly increased the likelihood of an unfavorable outcome in multivariate logistic regression analysis, which is needed to optimize anti-TB drug dosages and improve cure rates.
Journal ArticleDOI

Improving screening and chemoprophylaxis among child contacts in India's RNTCP: a pilot study.

TL;DR: In a programme setting, with HCW training and introduction of specific documentation (IPT card and register), implementation of contact tracing and chemoprophylaxis for child contacts improved from 19% to 61%.
Journal ArticleDOI

Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor–Based Antiretroviral Therapy in India

TL;DR: HIV-infected patients with tuberculosis who initiate nonnucleoside reverse-transcriptase-based anti-retroviral treatment in combination with rifampicin-based antituberculosis treatment demonstrate increases in total cholesterol, low- density cholesterol, and high-density cholesterol levels but no change in blood glucose level after 1 year.